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Gastrectomy reduces food intake and body weight (BW) hampering recovery of physical conditions. It also reduces plasma levels
of stomach-derived orexigenic ghrelin. This study explored changes in orexigenic ghrelin system in rats receiving total gastrectomy
with Billroth II (B-II) or Roux-en-Y (R-Y) method. Feeding and BW were reduced by gastrectomy and subsequently recovered to a
greater extent with R-Y than B-II while plasma ghrelin decreased similarly. At postoperative 12th week, ghrelin contents increased
in the duodenum and pancreas, plasma ghrelin levels increased upon fasting, and ghrelin injection promoted feeding but not in
earlier periods. In summary, gastrectomized rats partially recover feeding and BW, in a reconstruction-dependent manner. At 12th
week, ghrelin is upregulated in extra-stomach tissues, plasma ghrelin levels are physiologically regulated, and orexigenic eﬀect of
exogenous ghrelin is restored. This time-related recovery of ghrelin system may provide a strategy for promoting feeding, BW, and
thereby physical conditions in gastrectomized patients.
1.Introduction
Ghrelin, a 28-amino acid peptide, is produced mainly in
the stomach and to a lesser extent in the small intestine,
pancreas, and hypothalamus and is the endogenous ligand
for the growth hormone secretagogue receptor (GHS-R) [1–
9]. Serine-3 of ghrelin is acylated with an octanoic acid,
the process catalyzed by a recently discovered ghrelin O-
acyltransferase (GOAT) [10, 11]. The acylation is thought
to be required for its biological activity [1], although
desacyl ghrelin has been reported to exert several eﬀects
[12]. Administration of pharmacological doses of acylated
ghrelin (= ghrelin) to intact animals increases food intake,
induces body weight gain, and causes obesity [13–18]. The
orexigenic and body fat promoting properties of ghrelin
and growth hormone (GH) secretagogue (GHS) are thought
to be independent of GH and mediated primarily by the
hypothalamic neuropeptide Y (NPY) and agouti-related
protein (AGRP) systems [14–16, 19–22]. Although pharma-
cologic eﬀects of ghrelin are well documented, physiological2 International Journal of Peptides
role of endogenous ghrelin is poorly understood. It has
recently been reported that knockout of either the ghrelin
g e n eo rg h r e l i nr e c e p t o rg e n ee x e r t sn oo rm i n o re ﬀects
on body weight and body composition [23–25]. However,
the lack of phenotypic changes in knockout mice might
reﬂect compensatory mechanisms that are known to operate
occasionally.
In humans, gastrectomy results in loss of body weight of
about10%withintheﬁrstsixmonthsaftersurgery,primarily
due to reduced body fat [26]. In addition, gastrectomized
patients often complain of loss of appetite, general fatigue,
and in some cases impaired bone quality such as osteopenia
and osteomalacia [9, 27]. At present there are no satisfactory
mechanistic explanation and treatment for any of these
symptoms. The eﬀects of gastrectomy on food intake and
body composition have been poorly documented in rodents.
Loss of ghrelin could be implicated in these symptoms,
since as much as 80% of circulating ghrelin is lost following
surgical removal of the glandular stomach or the acid
producing part of the stomach in rats and humans [4, 28,
29].
In this study, we performed total gastrectomy in rats and
examined whether the recovery from gastrectomy-associated
anorexia depends on the circulating ghrelin level or other
factors and studied temporal changes in the biosynthesis and
orexigenic ability of ghrelin following gastrectomy.
2.MaterialsandMethods
2.1. Animals and Gastrectomy. Male 4-week-old Wistar rats
(SLC, Japan) were maintained on a 12-hour light/dark cycle
and given conventional food and water for 2 weeks and not
deprived of food before gastrectomy. They were operated
at 6 weeks of age with body weight around 130–180g.
Rats were anesthetized with an intraperitoneal injection of
pentobarbital (40mg/kg) and a median abdominal incision
was made. After the stomach was separated from the greater
and lesser omentum, the duodenal bulb was ligated and
transected. After the left gastric artery was ligated, the
esophagus was clamped above the esophagogastric junction
and the stomach was resected. An end-to-side anastomosis
between esophagus and jejunum at the 4-5cm anal side
from Treitz ligament was performed with 7–0 monoﬁlament
polyglyconate synthetic absorbable string (Maxon; Johnson
& Johnson Inc. USA) using interrupted suture (Billroth II
(B-II) reconstruction). On the other hand, jejunum was
transected at the 2-3cm anal side from the Treitz ligament.
Then, an end-to-side anastomosis between the esophagus
and jejunum was performed with 7–0 Maxon using an
interrupted suture. Jejunojejuno anastomosis was also done
by end-to-side method (Roux-en-Y (R-Y) reconstruction).
The abdominal wall and skin closure was made by 5–0 Nylon
(Johnson & Johnson Inc. USA) in a running suture. After
the operation, the rats were allowed only clear water without
food for 3 days, dry milk from the 3rd day, and from the 7th
day a conventional pellet diet with free access to water. The
care of the animals was in accordance with our institutional
guidelines.
2.2.MeasurementsofFoodIntakeandBodyWeights. Afterthe
operation, food intake for 24 hours and body weight were
measured once a week for 3 months.
2.3. Preparation of Blood and Tissue Samples. The rats were
sacriﬁced at three months after operation. To measure
plasma ghrelin concentrations, blood samples were collected
from the inferior vena cava of anaesthetized rats. Duodenum
samples of about 3cm were taken from 1cm anal side of
duodenal stump. Jejunum samples of about 3cm were taken
from 1cm anal side of esophagojejunostomy. Pancreatic
samples were also taken. The tissues were quickly frozen and
stored at −80
◦C until assaing.
2.4. RIAs Using Speciﬁc Antiserum and ELISA for Ghrelin.
Two kinds of rabbit polyclonal antiserum were used in
the present study. One antiserum was raised against the
COOH-terminally Cys-extended rat ghrelin (position 1-11)
in New Zealand white rabbits (#G606) that was shown
to speciﬁcally recognize ghrelin with n-octanoylated Ser 3
(acylated ghrelin; ghrelin). By the radioimmunoassay (RIA)
using this antiserum, designated NH2-terminal RIA (N-
RIA), the concentration of acylated ghrelin was obtained.
The other antiserum was raised against the NH2-terminally
Cys-extended rat ghrelin (position 13-28) (#G107) that was
shown to recognize both acylated ghrelin and desacyl ghrelin
[3]. By the RIA using this antiserum, named as COOH-
terminal RIA (C-RIA), the concentration of acylated ghrelin
plus desacyl ghrelin was obtained.
These two ghrelin-speciﬁc RIAs were used to measure
acylated ghrelin and desacyl ghrelin contents in several
tissues [3]. The bound and free ligands were separated
using a second antibody. “Acylated ghrelin” is expressed
as “ghrelin” and “acylated ghrelin plus desacyl ghrelin” is
expressed as “total ghrelin” throughout this text.
Plasma concentrations of acylated ghrelin and desacyl
ghrelin were measured using ELISA kits (Mitsubishi Kagaku
Iatron, Tokyo, Japan).
2.5. Treatment with Ghrelin. Ghrelin (Peptide Institute,
Osaka, Japan) or saline was administered subcutaneously
to control normal rats (eight-weeks-old) and those received
gastrectomy with B-II reconstruction. For ghrelin treatment
at 2 and 6 weeks after gastrectomy, the following procedures
were used. Control and gastrectomized rats were divided
into two groups; one group was treated with ghrelin and
the other with saline, and food intake and body weight were
measured.Theinjectionofghrelin(10nmol/kgbodyweight)
was carried out once a day for seven days, and food intake
and body weight were measured. For ghrelin treatment at
12 weeks after gastrectomy, the following procedures were
used. Single injection of ghrelin or saline was followed by
measurements of food intake for the subsequent 24 hours. In
the next week, two groups were changed: one group that had
ﬁrst received ghrelin was injected with saline, and the other
group that had ﬁrst received saline was injected with ghrelin.
Food intake after the ﬁrst injection and that after the second
injection were pooled and averaged.International Journal of Peptides 3
2.6. Statistical Analysis. Data represent the means ± SEM (n
= number of rats). Statistical analysis was performed using
Student’s paired and unpaired t-tests. Values of P<. 05 were
considered statistically signiﬁcant.
3. Results
3.1. Food Intake and Body Weight in Total Gastrectomized
Rats. Food intake for 24 hours and body weight were
measured in total gastrectomized and control rats during 12
postoperative weeks. Gastrectomy with B-II (n = 40) and R-
Yreconstructionmethods(n = 35)bothmarkedlydecreased
foodintake.InbothB-IIandR-Ygroups,atthe1stweekafter
operationfoodeatenfor24hoursdecreasedtoalevelaround
50% of that in control rats (Figure 1(a)). In B-II group the
reduced level of food intake continued for 12 weeks after
operation. In contrast, food intake in R-Y group increased
gradually during 4 postoperative weeks. The daily food
intake averaged for postoperative 12 weeks was signiﬁcantly
(P< . 05) reduced in B-II and R-Y groups (Figure 1(a)).
Food intake in R-Y group was signiﬁcantly (P<. 05) greater
than in B-II group throughout postoperative 12 weeks. Body
weight signiﬁcantly decreased after gastrectomy in both B-
II and R-Y groups (Figure 1(b)). Body weight in R-Y group
wassigniﬁcantlygreaterthanthatinB-IIgroupfromthe2nd
through 12th postoperative week (P<. 05).
The correlation between body weight, 24 hours food
intake, and plasma ghrelin concentrations at the 12th
postoperative week was studied. Food intake and body
weight were correlated with each other irrespective of recon-
struction methods and were plotted on a single regression
line (Figure 2(a)). In contrast, there was no correlation
between food intake and plasma concentrations of total
ghrelin (Figure 2(b)). We next examined whether body
weight correlates with plasma concentrations of ghrelin or
total ghrelin, by using N-RIA and C-RIA. Body weight
did not correlate with plasma ghrelin and total ghrelin
levels (Figures 2(c) and 2(d)). Furthermore, no signiﬁcant
diﬀerence between R-Y and B-II groups was observed in
averagedghrelinlevels(B-II:46.3 ± 7.2fmol/ml(n = 40),R-
Y: 35.9 ± 4.6fmol/ml(n = 35))andtotalghrelinlevels(B-II:
393.0 ± 40.0fmol/ml (n = 40), R-Y: 349.8 ± 23.2fmol/ml
(n = 35)), though some rats in B-II groups showed higher
levels of ghrelin and total ghrelin. These results indicate that
plasma ghrelin levels are signiﬁcantly reduced in R-Y and B-
II groups and that greater food intake in R-Y than in B-II
is related to the method of reconstruction but not plasma
ghrelin levels.
3.2. Plasma Ghrelin Concentrations and Ghrelin Contents
in Duodenum, Jejunum and Pancreas at 12th Postopera-
tive Week. Plasma ghrelin concentrations were markedly
reduced in both R-Y and B-II groups to the levels of
about 30% of those in control rats (Figure 3(a)). Stomach
produces approximately 70% of total ghrelin [3]. Therefore,
the reduction of plasma ghrelin levels is due to lack of
release of ghrelin from stomach. We examined whether the
reduction of ghrelin due to gastrectomy could inﬂuence the
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Figure 1: Daily food intake (a) and body weight (b) in rats for 12
weeks after total gastrectomy combined with Billroth II (B-II) or
Roux-en-Yreconstructionmethod(R-Y),andaftersham-operation
as the control. Gastrectomy was performed at 6 weeks of age. N = 6
for control, 40 for B-II and 35 for R-Y.
∗P< .05.
production of ghrelin in the intestine and pancreas, the
tissues known to produce ghrelin. Ghrelin concentrations
in the duodenum increased approximately by 100% in R-Y
and B-II groups (Figure 3(b)), while those in the jejunum
did not change (Figure 3(c)). Ghrelin concentrations in the
pancreas were much smaller than those in the intestine,
however,theydramaticallyincreasedapproximatelyby500%
in B-II and by 400% in R-Y groups (Figure 3(d)). On the
other hand, plasma concentrations of total ghrelin were
approximately ﬁve times higher than those of ghrelin, and
they were markedly reduced by gastrectomy in both groups
(Figure 3(e)). Contents of total ghrelin in the duodenum
and pancreas, but not jejunum, increased in both R-Y and
B-II groups (Figures 3(f)–3(h)). The gastrectomy-associated
relativechangesoftotalghrelininthecirculation,duodenum
and pancreas were similar to those of ghrelin. These results
suggest that gastrectomy-induced reductions in circulating4 International Journal of Peptides
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Figure 2: Relationship between daily food intake and body weight (a), between plasma total ghrelin concentrations and daily food intake
(b), between plasma ghrelin concentrations and body weight (c), and between plasma total ghrelin concentrations and body weight (d) in
ratsat12thweekaftertotalgastrectomycombinedwithB-IIorR-Yascomparedtothecontrolwithsham-operation.Ghrelinconcentrations
were determined with N-RIA in (c), and total ghrelin concentrations with C-RIA in (b) and (d). Total ghrelin corresponds to the sum of
ghrelin and desacyl ghrelin.
ghrelin levels promote synthesis of ghrelin in the duodenum
and pancreas, which may have compensatory roles including
the restoration of circulating ghrelin levels. In consistence
with this inference, plasma levels of ghrelin and total ghrelin
thatweremarkedlyreducedat2weeksaftergastrectomywith
B-II reconstruction (ghrelin: 25.0 ± 5.3fmol/ml (n = 4),
totalghrelin:295.8±34.6fmol/ml(n = 4))weresigniﬁcantly
(P<. 05) elevated at the 12th postgastrectomy week (ghrelin:
46.3 ± 7.1fmol/ml (n = 40), total ghrelin: 393.0 ± 40.0
fmol/ml (n = 40)).
3.3. Eﬀect of Fasting on Plasma Ghrelin Levels at 12th
Postoperative Week. We examined whether reduced levels
of plasma ghrelin after gastrectomy could be altered by
fasting, the physiological regulator of ghrelin release. At the
12th postoperative week, blood samples were taken from
ad-lib fed and 48 hour fasting rats. Eﬀects of fasting on
plasma levels of ghrelin and desacyl ghrelin were examined
by using ELISA, since RIA did not allow us to determine
exact levels of desacyl ghrelin. Plasma ghrelin concentrations
weresigniﬁcantly(P<. 05)elevatedbyfastingapproximately
by 3 times in both B-II and R-Y groups (Figures 4(a) and
4(c)). Desacyl ghrelin concentrations were also signiﬁcantly
(P<. 05) elevated by 3-4 times by fasting in B-II and R-Y
groups(Figures4(b)and4(d)).Thus,fastinginducedsimilar
foldincreasesinbothghrelinanddesacylghrelinlevelsinthe
circulation in gastrectomized rats.
3.4. Eﬀect of Ghrelin Injection on Food Intake in Control
and Gastrectomized Rats. Rats aged 8-weeks were dividedInternational Journal of Peptides 5
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Figure 3: Concentrations of ghrelin and total ghrelin in the plasma, intestine and pancreas after gastrectomy. Ghrelin and total ghrelin
concentrations in the plasma ((a), (e)) signiﬁcantly decreased, while those in the duodenum ((b), (f)) and pancreas ((d), (h)) signiﬁcantly
increased in rats at 12th week after total gastrectomy with B-II or R-Y, compared to the control with sham-operation (cont). In contrast,
neitherghrelin(c)nortotalghrelinconcentration(g)inthejejunumdiﬀeredamongB-II,R-Yandcontrolgroups.Concentrationsofghrelin
and total ghrelin were determined by N-RIA and C-RIA, respectively. N = 17 for control, 31 for B-II and 14 for R-Y.
∗P<. 05.
into two groups and received subcutaneous injection of
either saline or ghrelin once a day for seven continuous
days. Injection of ghrelin increased food intake, in which
signiﬁcant (P<. 05) diﬀerence was obtained at the 2nd,
4th and 5th days (Figure 5(a)). The cumulative food intake
during the treatment period of 7 days was signiﬁcantly (P<
.05) increased by ghrelin (Figure 5(b)).
At 2 weeks after total gastrectomy, rats were divided into
two groups and received subcutaneous injection of either
saline or ghrelin once a day for 7 continuous days. The 24
hoursfoodintakeaveragedforthetreatmentperiodof7days
was not signiﬁcantly diﬀerent between ghrelin-and saline-
treatedgroups(Figure 5(c)).Essentiallythesameresultswere
o b t a i n e di nr a t sa t6w e e k sa f t e rt o t a lg a s t r e c t o m y ;2 4h o u r s
food intake averaged for the treatment period of 7 days
was not diﬀerent between ghrelin-and saline-treated groups
(Figure 5(d)).
Atthe12thweekaftertotalgastrectomy,ratsweredivided
into two groups. One group received daily subcutaneous
injection of saline for a week followed by that of ghrelin for
the next week. Vice versa, the other group received ghrelin
for the ﬁrst week followed by saline for the next week. The
amount of 24 hours food intake in rats injected with ghrelin
was signiﬁcantly (P<. 05) greater than that with saline
(Figure 5(e)). These results indicate that ghrelin injection
increases food intake in the later stage of 12 weeks after
gastrectomy but not earlier.
4. Discussion
Ghrelin is secreted primarily from the stomach [9, 30], and
stimulates food intake and body weight gain. Gastrectomy
commonly decreases food intake, body weight, fat mass and
bone mass, and is also accompanied by a marked reduction6 International Journal of Peptides
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Figure 4: Plasma concentrations of ghrelin and desacyl ghrelin were signiﬁcantly elevated by fasting. Plasma concentrations of ghrelin ((a),
(c)) and desacyl ghrelin ((b), (d)) under fed condition and after 48 hour fasting in B-II group ((a), (b)) and R-Y group ((c), (d)) at 12th
postoperative week. Concentrations of ghrelin and desacyl ghrelin were determined by ELISA. N = 8f o rB - I Ia n d1 1f o rR - Y .∗:P<. 05.
in circulating ghrelin levels [31]. However, whether ghrelin
levels are causally related to food intake and/or body weight
aftergastrectomyisnotwellunderstood.Inthepresentstudy,
we produced total gastrectomized rat models and examined
postoperative changes in ghrelin levels, food intake and body
weight. Plasma ghrelin levels were markedly reduced by
gastrectomy irrespective to whether the reconstruction was
performed by B-II or R-Y method. However, the recovery
from gastrectomy-induced reductions in food intake and
body weight was much greater in R-Y than in B-II group.
The results indicate that the recovery from reduced food
intake and body weight after gastrectomy is not correlated
with circulating ghrelin levels but strongly depends on the
reconstruction method.
The mechanism for the better recovery of food intake
and body weight with R-Y method after total gastrec-
tomy remains unclear. Ghrelin contents in the duodenum,
jejunum and pancreas at 12th postoperative week were not
diﬀerent between B-II and R-Y methods. It is speculated that
in B-II method bile juice may directly reﬂux the esophago-
jejunostomy and consequently decrease food intake. Alter-
natively, shorter distance between esophagojejunostomy and
jejunojejunostomy in R-Y method than in B-II method may
yield smaller reﬂux of bile juice. It is suggested that selecting
the reconstruction method with less reﬂux of bile juice may
contribute to better recovery from the gastrectomy-induced
anorexia.
At the 12th week after gastrectomy, ghrelin production
was markedly enhanced in the duodenum, the organ known
to produce the second largest amount of ghrelin [3]. This
result was essentially the same between B-II and R-Y groups,
suggesting that the enhanced ghrelin production is not
related to the reconstruction method but likely due to the
removal of gastric ghrelin. It is therefore suggested that theInternational Journal of Peptides 7
15
16
17
18
19
20
F
o
o
d
i
n
t
a
k
e
(
g
/
d
a
y
)
∗
∗∗
0123456789
Post-operational days
Saline
Ghrelin
(a)
120
122
124
126
128
130
132
134
136
138
140
C
u
m
u
l
a
t
i
v
e
f
o
o
d
i
n
t
a
k
e
f
o
r
7
d
a
y
s
(
g
)
∗
Saline Ghrelin
(b)
8
9
10
11
F
o
o
d
i
n
t
a
k
e
(
g
/
d
a
y
)
2 weeks after gastrectomy
Saline Ghrelin
(c)
6
7
8
9
F
o
o
d
i
n
t
a
k
e
(
g
/
d
a
y
)
6 weeks after gastrectomy
Saline Ghrelin
(d)
7
8
9
10
F
o
o
d
i
n
t
a
k
e
(
g
/
d
a
y
)
∗
12 weeks after gastrectomy
Saline Ghrelin
(e)
Figure 5: Eﬀect of ghrelin injection on food intake in gastrectomized and control rats. (a) and (b): Ghrelin or saline was injected
subcutaneously to control rats once daily for 7 days, and daily food intake was measured for 10 days (a) and expressed by the cumulative
food intake for 7 days (b). Arrows indicate the time of injection of ghrelin or saline. N = 11 for saline and ghrelin.in (c), (d) and (e): Ghrelin
or saline was injected to rats once daily for 7 days at 2 (c), 6 (d) and 12 weeks (e) after total gastrectomy with B-II, and the daily food intake
averaged for 7 days is shown. N = 21 for saline and 22 for ghrelin in (c). N = 21 for saline and 20 for ghrelin in (d). N = 37 for saline and
g h r e l i ni n( e ) .
∗P< 0.05.
enhanced ghrelin production in the duodenum could partly
compensate for gastrectomy-associated reductions of the
circulating ghrelin and its endocrine functions. In another
line of experiments, at 12th postoperative week fasting
markedly increased plasma ghrelin levels in gastrectomized
rats, indicating that the tissue other than stomach, most
likely the duodenum, secretes ghrelin in response to fasting,
the physiological regulator of ghrelin secretion [9, 32].
Furthermore, the feeding response to peripheral ghrelin
administration was once eliminated by gastrectomy but
restored at 12th postoperative week. These data suggest that
ghrelin can be released and stimulate food intake under
fasted conditions at this later period after gastrectomy.
Collectively, the markedly upregulated production of ghrelin
in the duodenum could contribute to the recovery of food
intake and body weight in the later postoperative period.
In this study, ghrelin production was also signiﬁcantly
elevated in the pancreas. Since the ghrelin content in the
pancreas and its increment due to gastrectomy are much
smaller than those in the duodenum, they may neither
signiﬁcantly contribute to the circulating ghrelin levels nor
operate endocrine functions. However, previous studies
usingghrelinreceptorantagonistsandghrelin-deﬁcientmice
have demonstrated that ghrelin in the pancreatic islets
inhibitsinsulinreleaseinanautocrine/paracrinemannerand
consequently regulate blood glucose levels [33, 34]. The late
postprandialdumpingsyndromeaccompanyinggastrectomy
is characterized by hypoglycemia principally due to excessive
insulin release. The mechanism for excessive insulin release
remains unclear, lack of the stomach-derived ghrelin could
be implicated. If so, it is possible that upregulated pancreatic
ghrelin compensates lack of stomach-derived ghrelin and8 International Journal of Peptides
attenuate insulin release, thereby counteracting the hypo-
glycemia in the late dumping syndrome. Further study is
necessary to elucidate the role and mechanism for the
upregulation of ghrelin production in the pancreas after
gastrectomy.
It has been well documented that administration of
pharmacological doses of ghrelin to intact animals increases
food intake, induces weight gain, and causes obesity [9, 13–
18]. Ghrelin injection failed to stimulate food intake in
the early stages of 2nd to 6th week after operation, but
increased it in the late stage of 12th week. The results
suggest that some machinery that links ghrelin reception to
feedingdysfunctionsaftergastrectomybutcanberestored.A
candidate for such machinery is the vagal nerve. It has been
reported that the peripheral injection of ghrelin does not
increase food intake after cutting vagus nerve [15, 30, 35]. It
is thought that peripheral ghrelin signal is transmitted to the
feeding center at least partly via aﬀerent vagal nerves [15, 30,
35]. In our study, vagus nerves that were cut by the operation
of gastrectomy may be regenerated later. It is speculated that
regeneration of vagus nerves takes place not immediately
but time-dependently, allowing reception of injected ghrelin
and transmission of its signal to the feeding center. In
addition, chronic hypoghrelinemia in gastrectomized status
was reported to induce hypersensitivity to ghrelin as judged
by secretion of growth hormone [36]. If this is also the
case for the orexigenic action of ghrelin, the hypersensitivity
to ghrelin could make the ghrelin injection more potent
and/or eﬃcacious in correcting anorexia after gastrectomy.
Collectively, in the certain period when vagus nerves are
regenerated and sensitivity to ghrelin is elevated, ghrelin
treatment is expected to eﬀectively stimulate feeding. In fact,
the fractional increase of food intake in response to ghrelin
injection at 12th postoperative week was similar to that in
control rats (Figures 5(e) versus 5(a)). Thus, our results
raise a possibility that ghrelin replacement therapy given in
later stages could be eﬀective in promoting food intake and
correcting some symptoms associated with gastrectomy in
humans.
Another health problem with dysregulated body weight
and feeding is obesity. Obesity often causes hyperglycemia,
hypertension and/or dyslipidemia, forming metabolic syn-
drome. Obesity and metabolic syndrome are major risk
factors for cardiovascular disease. The rapidly increasing
incidence of obesity has become a serious worldwide health
problem [37]. An eﬀective treatment of severe obesity is
bariatric surgery, in which gastric bypass is a representative
method. Gastric bypass, as well as gastrectomy, markedly
reduces appetite and body weight, suggesting that changes
in plasma ghrelin levels are involved. However, studies
on changes in plasma ghrelin levels after gastric bypass
have yielded inconsistent results; decreased, unchanged,
or increased [38–40] .I no u rs t u d y ,b e t t e rr e s t o r a t i o ni n
feeding and body weight after gastrectomy was obtained
with R-Y than B-II method, while plasma ghrelin levels
were similar. These observations by us and others collec-
tively suggest that feeding and body weight in the earlier
period after gastric surgery, are not associated with plasma
ghrelin levels but determined by other factors, possibly
reconstruction methods associated with speciﬁc histological
conditions.
In summary, recovery from gastrectomy-induced reduc-
tions in food intake and body weight is not related to plasma
ghrelin levels but depends on the reconstruction method
in rats. At postoperational 12th week, ghrelin production is
increased in the duodenum and pancreas, and circulating
ghrelin level is elevated by fasting, suggesting that ghrelin
could be released from extra-stomach tissues and play a
compensatory role. Ghrelin administration stimulates feed-
ing at postoperational 12th week but not earlier, suggesting
that ghrelin treatment in later periods could be eﬀective
in treating patients with gastrectomy-induced anorexia and
associated symptoms.
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